STRUCTURAL AND MOLECULAR ADAPTATIONS TO DEXAMETHASONE AND UNACYLATED GHRELIN ADMINISTRATION IN SKELETAL MUSCLE OF THE MICE

被引:9
作者
Canepari, M. [1 ,2 ]
Agoni, V [1 ,2 ]
Brocca, L. [1 ,2 ]
Ghigo, E. [3 ]
Gnesi, M. [7 ]
Minetto, M. A. [3 ,4 ]
Bottinelli, R. [1 ,2 ,5 ,6 ]
机构
[1] Univ Pavia, Dept Mol Med, Via Forlanini 6, I-27100 Pavia, Italy
[2] Univ Pavia, Interuniv Inst Myol, Pavia, Italy
[3] Univ Turin, Dept Med Sci, Div Endocrinol & Metab, Turin, Italy
[4] Univ Turin, Dept Surg Sci, Div Phys Med & Rehabil, Turin, Italy
[5] Univ Pavia, Sci Inst Pavia, Fdn Salvatore Maugeri IRCCS, Pavia, Italy
[6] Univ Pavia, Interdept Ctr Biol & Sport Med, Pavia, Italy
[7] Univ Pavia, Sect Biostat & Clin Epidemiol, Dept Publ Hlth Expt & Forens Med, Pavia, Italy
来源
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2018年 / 69卷 / 02期
关键词
glucocorticoids; dexamethasone; steroid myopathy; unacylated ghrelin; muscle atrophy; 1 NULL MICE; MITOCHONDRIAL DYSFUNCTION; GLUCOCORTICOID-RECEPTOR; UP-REGULATION; ATROPHY; EXPRESSION; UBIQUITIN; MECHANISMS; ATROGIN-1; PROTEINS;
D O I
10.26402/jpp.2018.2.14
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The central goal of this study was to identify the primary mechanisms triggering steroid atrophy. Adaptations of soleus (Sol) and vastus lateralis (VL) muscles of C57BL/6 female mice were studied following 3, 7 and 15 days of daily intraperitoneal injection (5 mg kg(-1) day(-1)) of dexamethasone (DEX) (chronic treatment) and 1, 3 and 10 hours after a single DEX injection (acute treatment). In the chronic treatment, analyses were performed 24 hours after the last injection. Gene expression of major components of the intracellular signalling pathways controlling mass and metabolism were assessed. Analyses were repeated following DEX and unacylated ghrelin (UAG) (100 mu g kg(-1)day(-1)), co-administration. We found a significant VL fibres atrophy after 7 (13%) and 15 (28%) days and a Sol fibres atrophy (23%) after 15 days of DEX treatment. The acute treatment showed, in both muscles, several responses in most signalling pathways, among which the enhanced gene expression of Murf-1 (6-fold change in VL and 3-fold in Sol) and myostatin (6-fold change in VL and 20-fold in Sol). In Sol, UAG administration was able to fully counteract muscle atrophy and Murf-1 upregulation, but not the upregulation of myostatin, suggesting a causal relationship between muscle atrophy and Murf-1. Results indicate that: a) the primary mechanism triggering steroid atrophy is an early transient activation of Murf-1; b) UAG inhibits Murf-1 induction counteracting steroid atrophy. The present work contributes to the understanding of the complexity of the muscle response to glucocorticoids.
引用
收藏
页码:283 / 296
页数:14
相关论文
共 51 条
  • [1] Allas S, 2013, ENDOCR DEV, V25, P157, DOI 10.1159/000346065
  • [2] Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids
    Baehr, Leslie M.
    Furlow, J. David
    Bodine, Sue C.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2011, 589 (19): : 4759 - 4776
  • [3] Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis
    Braun, Thomas
    Gautel, Mathias
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2011, 12 (06) : 349 - 361
  • [4] Nitric oxide release combined with nonsteroidal anti inflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy
    Brunelli, Silvia
    Sciorati, Clara
    D'Antona, Giuseppe
    Innocenzi, Anna
    Covarello, Diego
    Galvez, Beatriz G.
    Perrotta, Cristiana
    Monopoli, Angela
    Sanvito, Francesca
    Bottinelli, Roberto
    Ongini, Ennio
    Cossu, Giulio
    Clementi, Emilio
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (01) : 264 - 269
  • [5] Glucocorticoid-induced apoptosis and cellular mechanisms of myopathy
    Dirks-Naylor, Amie J.
    Griffiths, Carrie L.
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2009, 117 (1-3) : 1 - 7
  • [6] Dobrzynska Z, 2016, J PHYSIOL PHARMACOL, V67, P139
  • [7] Dynamic regulation of mitochondrial function by glucocorticoids
    Du, Jing
    Wang, Yun
    Hunter, Richard
    Wei, Yanling
    Blumenthal, Rayah
    Falke, Cynthia
    Khairova, Rushaniya
    Zhou, Rulun
    Yuan, Peixiong
    Machado-Vieira, Rodrigo
    McEwen, Bruce S.
    Manji, Husseini K.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (09) : 3543 - 3548
  • [8] Altered gene expression patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle atrophy
    Furlow, J. David
    Watson, Monica L.
    Waddell, David S.
    Neff, Eric S.
    Baehr, Leslie M.
    Ross, Adam P.
    Bodine, Sue C.
    [J]. PHYSIOLOGICAL GENOMICS, 2013, 45 (23) : 1168 - 1185
  • [9] Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy
    Gilson, H.
    Schakman, O.
    Combaret, L.
    Lause, P.
    Grobet, L.
    Attaix, D.
    Ketelslegers, J. M.
    Thissen, J. P.
    [J]. ENDOCRINOLOGY, 2007, 148 (01) : 452 - 460
  • [10] Gomez-Sanmiguel AB, 2017, J PHYSIOL PHARMACOL, V68, P191